Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002861 |
---|---|
Receipt number | R000003492 |
Scientific Title | A phase II study of erlotinib for patients with pretreated non-small cell lung cancer with brain metastasis and sensitive EGFR mutations. |
Date of disclosure of the study information | 2009/12/08 |
Last modified on | 2013/01/30 13:34:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/12/08 19:12:46 | ||
2 | Update | 2013/01/30 13:34:18 | Date of closure to data entry Date trial data considered complete Date analysis concluded Results |